Literature DB >> 9121456

High levels of human gamma-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin.

M O Arcasoy1, M Romana, M E Fabry, E Skarpidi, R L Nagel, B G Forget.   

Abstract

Persistent expression of the gamma-globin genes in adults with deletion types of hereditary persistence of fetal hemoglobin (HPFH) is thought to be mediated by enhancer-like effects of DNA sequences at the 3' breakpoints of the deletions. A transgenic mouse model of deletion-type HPFH was generated by using a DNA fragment containing both human gamma-globin genes and HPFH-2 breakpoint DNA sequences linked to the core sequences of the locus control region (LCR) of the human beta-globin gene cluster. Analysis of gamma-globin expression in six HPFH transgenic lines demonstrated persistence of gamma-globin mRNA and peptides in erythrocytes of adult HPFH transgenic mice. Analysis of the hemoglobin phenotype of adult HPFH transgenic animals by isoelectric focusing showed the presence of hybrid mouse alpha2-human gamma2 tetramers as well as human gamma4 homotetramers (hemoglobin Bart's). In contrast, correct developmental regulation of the gamma-globin genes with essentially absent gamma-globin gene expression in adult erythroid cells was observed in two control non-HPFH transgenic lines, consistent with autonomous silencing of normal human gamma-globin expression in adult transgenic mice. Interestingly, marked preferential overexpression of the LCR-distal (A)gamma-globin gene but not of the LCR-proximal (G)gamma-globin gene was observed at all developmental stages in erythroid cells of HPFH-2 transgenic mice. These findings were also associated with the formation of a DNase I-hypersensitive site in the HPFH-2 breakpoint DNA of transgenic murine erythroid cells, as occurs in normal human erythroid cells in vivo. These results indicate that breakpoint DNA sequences in deletion-type HPFH-2 can modify the developmentally regulated expression of the gamma-globin genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121456      PMCID: PMC232055          DOI: 10.1128/MCB.17.4.2076

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  DNA sequence variation associated with elevated fetal G gamma globin production.

Authors:  J G Gilman; T H Huisman
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

2.  The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions.

Authors:  T H Huisman; W A Schroeder; G D Efremov; H Duma; B Mladenovski; C B Hyman; E A Rachmilewitz; N Bouver; A Miller; A Brodie; J R Shelton; J B Shelton; G Apell
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

3.  G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene.

Authors:  F S Collins; C J Stoeckert; G R Serjeant; B G Forget; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

4.  Heterogeneity in the molecular basis of three types of hereditary persistence of fetal hemoglobin and the relative synthesis of the G gamma and A gamma types of gamma chain.

Authors:  A Kutlar; M B Gardiner; M G Headlee; A L Reese; M P Cleek; S Nagle; P K Sukumaran; T H Huisman
Journal:  Biochem Genet       Date:  1984-02       Impact factor: 1.890

5.  Mapping of DNase I-hypersensitive sites in the upstream DNA of human embryonic epsilon-globin gene in K562 leukemia cells.

Authors:  D Tuan; I M London
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 6.  The molecular genetics of human hemoglobin.

Authors:  F S Collins; S M Weissman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1984

7.  High performance liquid chromatographic separation of the globin chains of non-human hemoglobins.

Authors:  W A Schroeder; J B Shelton; J R Shelton; V Huynh; D B Teplow
Journal:  Hemoglobin       Date:  1985       Impact factor: 0.849

8.  A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.

Authors:  M E Fabry; A Sengupta; S M Suzuka; F Costantini; E M Rubin; J Hofrichter; G Christoph; E Manci; D Culberson; S M Factor; R L Nagel
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

9.  An embryonic pattern of expression of a human fetal globin gene in transgenic mice.

Authors:  K Chada; J Magram; F Costantini
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

10.  A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia.

Authors:  B Giglioni; C Casini; R Mantovani; S Merli; P Comi; S Ottolenghi; G Saglio; C Camaschella; U Mazza
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

View more
  8 in total

Review 1.  Control of globin gene expression during development and erythroid differentiation.

Authors:  George Stamatoyannopoulos
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

Review 2.  Regulation of human fetal hemoglobin: new players, new complexities.

Authors:  Arthur Bank
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

3.  Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin.

Authors:  Khaimuk Changsri; Varaporn Akkarapathumwong; Duangporn Jamsai; Pranee Winichagoon; Suthat Fucharoen
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

4.  Effects of human gamma-globin in murine beta-thalassaemia.

Authors:  Tamon Nishino; Hua Cao; George Stamatoyannopoulos; David W Emery
Journal:  Br J Haematol       Date:  2006-07       Impact factor: 6.998

5.  Analysis of the mechanism of action of non-deletion hereditary persistence of fetal hemoglobin mutants in transgenic mice.

Authors:  Q Li; Z J Duan; G Stamatoyannopoulos
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

6.  Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and deltabeta-thalassemia affects beta- but not gamma-globin gene expression.

Authors:  R Calzolari; T McMorrow; N Yannoutsos; A Langeveld; F Grosveld
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

7.  Persistent fetal gamma-globin expression in adult transgenic mice following deletion of two silencer elements located 3' to the human Agamma-globin gene.

Authors:  Maria Gazouli; Eleni Katsantoni; Theodoros Kosteas; Nicholas P Anagnou
Journal:  Mol Med       Date:  2009-08-10       Impact factor: 6.354

8.  Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.

Authors:  Matthew E Hardee; Yiting Cao; Ping Fu; Xiaohong Jiang; Yulin Zhao; Zahid N Rabbani; Zeljko Vujaskovic; Mark W Dewhirst; Murat O Arcasoy
Journal:  PLoS One       Date:  2007-06-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.